个人简历

学习经历
2003.9-2006.6 澳门科技大学 中医学（临床研究）博士学位
1999.9-2003.6 南京中医药大学 医学硕士学位
1991.9-1996.6 徐州医学院（现徐州医科大学） 医学学士学位
教学经验 2012澳门科技大学中医药学院副教授
2018.6-2018.7 科英布拉大学暑期研修课程（2018 澳门高校教研人才培训计划）
2017.6-2017.7剑桥大学暑期研修课程（2017 澳门高校教研人才培训计划）
2006-2012 澳门科技大学中医药学院助理教授
2001-2006 南京中医药大学内科学教研室、诊断学教研室讲师、教研室副主任、主任；中 西医结合系副主任
南京中医药大学附属医院（江苏省中医院）内科（呼吸科）主治医师
1996-2001南京中医药大学内科学教研室助教
南京中医药大学附属医院（江苏省中医院）内科（呼吸科）住院医师
1997.3-1998.4南京大学附属鼓楼医院内科进修医生
教学：
（本 科）诊断学；内科学；生理学；急救医学等；
（研究生）诊断学进展；内科学进展；中西医结合研究进展等。

研究领域

中西医结合；胸肺疾病、肿瘤中西医结合治疗的循证与实验研究。"研究项目
2019细胞自噬在非小细胞肺癌 TKIs 耐药中的角色及榄香烯的干预作用与机制研究（澳门特别行政 区科学技术发展基金）
2018中药榄香烯治疗非小细胞肺癌的靶标发现及逆转酪氨酸激酶抑制剂耐药的机制研究（澳门特别行政区科学技术发展基金） 2013-2017 麝香酮抗大鼠心肌缺血-再灌注损伤的子机制研究（澳门特别行政区科学技术发展基金）
2013科普夏令营--生理之谜与生命之吻--人体健康知识与实用急救技能（澳门特别行政区科学技术 发展基金） 2012 科普夏令营--青少年健康知识与实用急救技能（澳门特别行政区科学技术发展基金） 2011 科普夏令营--探索人体的奥秘：人体的结构与功能（澳门特别行政区科学技术发展基金） 2008-2012 人工麝香口崩片抗心绞痛作用机制的研究（澳门特别行政区科学技术发展基金）
2005-2009支扩宁合剂对支气管扩张症气道炎症、气道重塑的干预作用的分子机制与临床研究（澳门特别行政区科学技术发展基金）
2005-2006支气管上皮细胞及其细胞因子在支扩发病中的作用与中药干预的体外研究（江苏省高校自然科学研究计划指导项目） 2002-2005 支扩宁合剂治疗支气管扩张症及其对 NE 和 ECM 的作用研究（江苏省科技厅社会发展项目）
专利：
1.人工麝香和单硝酸异山梨酯复方口崩片及其制备方法（CN200910203327.8），国家知识产权局
2.人工麝香中麝香酮的血药浓度定量分析方法（CN201210097458.4），国家知识产权局"

近期论文

期刊文章（近 5 年）： (*通讯作者; #第一作者)
1.QibiaoWu*,Elaine Lai HanLeung*.Associationofdietaryfiberandyogurt consumptionwith lungcancerrisk. JAMAOncology.2020.doi:10.1001/jamaoncol.2020.0261.
2.2. PengChen#,QibiaoWu #,Yuxiang, MingmingZhang, JiaoFeng,ShuipingLiu,TingDuan, LijuanZhai,BingtaoZhai,WengangWang,RuonanZhang, LiuxiChen, BiChen, Xuemeng Han, XiayingChen,YicongLi,YingLiu,XingxingHuang,TingPan,LiliYan,TingJin,Wenzheng Zhang,HongLuo,XiaohuiChen,YongqiangLi, QiujieLi,Guohua Li, QinZhang,LvjjiaZhuo,
ZuyiYang,HuifenTang,TianXie*,XiaopingOuyang*,XinbingSui*.Eranin, anovel dibenzyl compoundinDendrobiumextract,inhibits lungcancer cellgrowth andmigrationvia calcium /calmodulin-dependentferroptosis.SignalTransductionandTargetedTherapy.2020,5:51.doi: 10.1038/s41392-020-0149-3.
3.QibiaoWu*,Elaine Lai HanLeung*.CommentaryonGeetal.“Insomnia andriskofmortality fromall-cause,cardiovasculardisease,andcancer: Systematicreview andmeta-analysis of prospectivecohortstudies”.SleepMedicineReviews, 2020Jan8;50:101257.doi: 10.1016/j.smrv.2019.101257.
4. ShengdaLuo,Jiahui Xu, ZeboJiang, LeiLiu, QibiaoWu*,Elaine Lai-Han Leung*,AlexPo Leung*.Artificialintelligence-based collaborativefiltering methodwith ensemblelearningfor personalizedlungcancermedicinewithout geneticsequencing. PharmacolRes.2020Jun 23;160:105037.doi:10.1016/j.phrs.2020.105037.
5. XiaoqingFan,Zebo Jiang,YuweiWang,XiaoqingFan, JunCai,XiaojunYao,LiangLiu, Jun Huang,JianxingHe,ChunXie,QibiaoWu*,YabingCao*,Elaine Lai-HanLeung*.Modulation ofgutmicrobiotatoovercomeresistance toimmune checkpoint blockadeincancer immunotherapy.CurrOpinPharmacol.2020Jun30;54:1-10.doi:10.1016/j.coph.2020.06.004.
6. ZhangRuonan, PanTing,XiangYu,ZhangMingming, FengJiao,LiuShuiping,DuanTing,Chen Peng,Zhai Bingtao,ChenXiaying,WangWengang,ChenBi,HanXuemeng, ChenLiuxi,YanLili, JinTing,LiuYing, Li Guohua,HuangXingxing, ZhangWenzheng,SunYitian, Li Qiujie,Zhang Qin, ZhuoLvjia,XieTian*,WuQibiao*,Sui Xinbing*. β-ElemeneReversesthe Resistanceof p53-DeficientColorectalCancerCells to5-FluorouracilbyInducingPro-deathAutophagyand CyclinD3-DependentCycleArrest.Front.Bioeng. Biotechnol.2020,8:378.doi: 10.3389/fbioe.2020.00378.
7. BiChen, RuoNanZhang, Xingxing Fan,JueWang,Cong Xu,BoAn, QiaoWang,JingWang, ElaineLai-Han Leung*, XinbingSui*, Qi-BiaoWu*.Clinical diagnosticvalue oflong non-codingRNAs incolorectalcancerAsystematicreview andmeta-analysis.Journal ofCancer, 2020;11(18):5518-5526.doi:10.7150/jca.46358.
8. HuiYou #,Yi-ZhongZhang#,Huan-Ling Lai#,DanLi,Yu-QuanLiu,Run-Ze Li,ImranKhan, WendyWen-Lun Hsiao,Fu-Gang Dua,Xing-XingFan, Xiao-JunYao,Ya-BingCao, Qi-BiaoWu*, ElaineLai-Han Leung*, Mei-FangWang*.Prognosticsignificanceoftumorpoliovirus receptor andCTLA4expressioninpatients withsurgicallyresectednon-small celllungcancer.JCancer ResClinOncol.2020Apr4.doi:10.1007/s00432-020-03189-8.
9. BingtaoZhai#,QibiaoWu#,WengangWang,MingmingZhang,XuemengHan, QiujieLi, Peng Chen,Xiaying Chen,XingxingHuang,GuohuaLi,QinZhang, RuonanZhang,YuXiang, ShuipingLiu,TingDuan,JianshuLou,TianXie*, XinbingSui*. Preparation,Characterization, Pharmacokinetics andAnticancerEffects ofPEGylatedβ-ElemeneLiposomes.CancerBiology& Medicine.2020.doi:10.20892/j.issn.2095-3941.2019.0156. 10. Cong Xu #, XiaojunYao #,Ting Li, JueWang, XinbingSui*, Elaine LaiHan Leung*, QibiaoWu*. Pretreatmentneutrophil-to-lymphocyteratioisapredictivebiomarker forEGFRTKI-treated patients withadvancedEGFR-mutantNon-small celllungcancer.Transl CancerRes.2020.doi:
10.21037/tcr.2020.02.28.
11. HongweiChen, XiaojunYao,TingLi, ChristopherWai-KeiLam, RuonanZhang, HuixiaZhang, JueWang,WeiZhang*,ElaineLai-Han Leung*,QibiaoWu*.CompoundKusheninjection
combinedwithplatinum-basedchemotherapyforstage III/IVnon-smallcell lungcancer:A meta-analysis of37RCTsfollowingthe PRISMAguidelines.JCancer.2020;11(7):1883-1898. doi:10.7150/jca.40267.
12.XiaomingHuang#,JueWang#,WanjunLin, NaZhang,Jingjing Du,Ze Long,YouYang,Bowen Zheng,FangfangZhong,QibiaoWu*,WenzheMa*.Kanglaiteinjectionplusplatinum-based chemotherapyfor stageIII/IVnon-smallcell lungcancer:Ameta-analysis of27RCTs, Phytomedicine,67,2020,153154,https://doi.org/10.1016/j.phymed.2019.153154.
13. QingqingGuo, ShijinYang,DongqingYang,NingZhang,XunLi,Tianli Chen,JiayanChen, GuochunLi*,LianYin*,QibiaoWu*.DifferentialmRNAexpressioncombinedwithnetwork pharmacologyreveals networkeffects ofLiangxueTongyu Prescriptionfor acuteintracerebral hemorrhagicrats.JEthnopharmacol. 2020Jan10;246:112231.doi:10.1016/j.jep.2019.112231. Epub2019Sep11.
14. Jiahui Xu#,QianqianWang#,ElaineLai HanLeung#,YingLi,XingxingFan, QibiaoWu*,Xiaojun Yao*,LiangLiu*.CompoundC620-0696,anewpotentinhibitortargetingBPTF,thechromatin remodelingfactorinnon-small celllungcancer.FrontMed.2020Feb;14(1):60-67.doi: 10.1007/s11684-019-0694-8.
15. QibiaoWu*;XiaojunYao#;HongweiChen#;TingLi,XingxingFan; GuilinZhang; LiliYu;Min Chen; CongXu; RuonanZhang; BiChen; XinbingSui*;Elaine Lai-HanLeung*.Long-term aspirinuseforprimarycancerprevention:Anupdatedsystematic reviewand subgroup meta-analysis of29randomizedclinicaltrials. Journal ofCancer,2020(inpress).
16. Ya-JiaXie#,Wei-NaGao#,Qi-BiaoWu,Xiao-JunYao,Ze-BoJiang,Yu-WeiWang,Wen-Jun Wang,WeiLi,ShahidHussain,Liang Liu*,Elaine Lai-Han Leung*, Xing-XingFan,*. Chelidonineselectivelyinhibits the growthofgefitinib-resistant non-small celllungcancercells throughtheEGFR-AMPKpathway.Pharmacol Res.2020;159:104934. doi:10.1016/j.phrs.2020.104934.
17. QiSong#,JieZhang#,QibiaoWu,GuopingLi*,ElaineLai-Han Leung*.Kanglaite injectionplus Fluorouracil-basedchemotherapyonthe reductionofadverse effectsandimprovementofclinical effectivenessinpatients withadvancedmalignanttumorsofthedigestive tract:Ameta-analysis of 20RCTsfollowingthe PRISMAguidelines. Medicine(Baltimore).2020Apr;99(17):e19480.doi: 10.1097/MD.0000000000019480.
18. HongweiChen#,XiaojunYao#,TingLi,ChristopherWai-KeiLam, Huixia Zhang, JueWang,Wei Zhang,Elaine Lai HanLeung*,QibiaoWu*.Compound Kusheninjectionplusplatinum-based chemotherapyfor stageIIIB/IVnon-smallcelllungcancer:Aprotocolformeta-analysis of randomizedclinicaltrialsfollowingthe PRISMAguidelines.Medicine(Baltimore).2019 Dec;98(52):e18552.doi:10.1097/MD.0000000000018552.
19. LiuxiChen#,YingLiu#,QiZhang#,MingmingZhang,XuemengHan, QiujieLi,TianXie*,Qibiao Wu*,XinbingSui*. p53/PCDH17/Beclin-1 ProteinsasPrognosticPredictorsforUrinaryBladder Cancer.JCancer.2019Oct15;10(25):6207-6216.doi:10.7150/jca.37335.eCollection2019.
20. QiBiaoWu*,ElaineLai HanLeung*.The evidence strengthofameta-analysis ofaspirinfor primarypreventionofcancer.JCancerResClin Oncol.2019Oct31.doi: 10.1007/s00432-019-03069-w. 21. QibiaoWu*,Hongwei Chen#,XiaojunYao#,TingLi,CongXu, JueWang,XinbingSui*,Elaine Lai HanLeung∗ .Long-termaspirinusefor cancerprimaryprevention:Aprotocolforupdated
systematicreview andsubgroupmeta-analysis ofrandomizedclinical trials.Medicine(Baltimore). 2019Sep;98(39):e17382.doi:10.1097/MD.0000000000017382.
22.HongweiChen#,XiaojunYao#,ZhengtangLiu#,TingLi,CongXu, JueWang,XinbingSui*, ElaineLai HanLeung*,QibiaoWu*.EfficacyandsafetyofShenqi Fuzhenginjectioncombined withplatinum-basedchemotherapyforstageIII/IVnon-smallcelllungcancer:Aprotocolfor systematicreview andmeta-analysis ofrandomized controlledtrials. Medicine(Baltimore).2019 Sep;98(39):e17350.doi:10.1097/MD.0000000000017350.
23. QiChen, JuanLiu,YuxinZhuang,Liping Bai,QingYuan,Silin Zheng,KangshengLiao,Md. AsaduzzamanKhan,QibiaoWu,ChengLuo, LiuLiang,HuiWang*,TingLi*.Identificationof anIKKβinhibitorfor inhibitionofinflammationinvivoandinvitro.PharmacolRes. 2019 Nov;149:104440.doi:10.1016/j.phrs.2019.104440.Epub2019Aug31.
24. YuweiWang,ChunpingTang,ShengYao,HuanlingLai,Runze Li,Jiahui Xu, QianqianWang, XingXingFan, QiBiaoWu,ElaineLai HanLeung*,YangYe*,XiaojunYao*.Discoveryofa novel proteinkinase C activatorfromCrotontiglium forinhibitionofnon-smallcelllungcancer. Phytomedicine.2019Dec;65:153100.doi:10.1016/j.phymed.2019.153100.
25. FugangDuan,MeifangWang,YabingCao,DanLi, RunzeLi,Xingxing Fan,ImranKhan, HuanlingLai,Yizhong Zhang,WendyWenluanHsiao,XiaojunYao,QibiaoWu,Liang Liu*, YijunTang*,Elaine Lai HanLeung*.MicroRNA-421confers paclitaxelresistance bybindingto theKEAP13'UTR andpredictspoorsurvivalinnon-smallcelllungcancer.Cell DeathDis. 2019 Oct28;10(11):821.doi:10.1038/s41419-019-2031-1.
26. ElaineLai HanLeung*,QibiaoWu*.Concurrent useofherbalproductswith prescriptiondrugs is adouble-edged swordandevidence-based medicinecontributes toreshapingthepractice, PharmacologicalResearch,2019.pii:S1043-6618(19)30088-X.doi:10.1016/j.phrs.2019.01.033.
27. XingpingWu#,QibiaoWu#*,XiqiaoZhou#,JiananHuang*.SphK1functions downstreamof IGF-1tomodulateIGF-1-inducedEMT,migrationandpaclitaxel resistanceofA549cells:A preliminaryinvitrostudy.JCancer,2019,10(18):4264-4269.doi:10.7150/jca.32646.
28. ShuangLin,XiaoxiaAn,YongGuo,JianzhongGu,TianXie*, QibiaoWu*,XinbingSui*. Meta-AnalysisofAstragalus-ContainingTraditionalChineseMedicine CombinedWith ChemotherapyforColorectalCancer:EfficacyandSafetytoTumorResponse.Front. Oncol., 2019,9:749.doi:10.3389/fonc.2019.00749.
29. HongweiChen, JueWang,ZhengLi,ChristopherWaiKeiLam,YingXiao*,QibiaoWu*,Wei Zhang*.ConsumptionofSugar-SweetenedBeverages HasaDose-DependentEffectonthe Riskof Non-AlcoholicFattyLiver Disease:AnUpdatedSystematic ReviewandDose-Response Meta-Analysis.IntJEnvironResPublicHealth,2019Jun21;16(12).pii:E2192.doi: 10.3390/ijerph16122192.
30. Yiwei Zhang,JuanZhang,JiaqiHu, ChunleiWen, ShuyangDai,DanfengYang,LifangLi,Qibiao Wu*.Neuraxial adjuvants forpreventionofperioperative shiveringduring cesareansection:A networkmetaanalysis followingthePRISMAguidelines.WorldJClinCases,2019;7(16): 2287-2301.doi:https://dx.doi.org/10.12998/wjcc.v7.i16.0000.
31. JuanLiu, LipingBai,FenYang, XiaojunYao,Kawai Lei,ChristopherWaiKeiLam, QibiaoWu, YuxinZhuang,RipingXiao,KangshengLiao,Hioha Kuok,TingLi*,LiangLiu*.Potent Antagonists ofRORγt,CardenolidesfromCalotropisgigantea,ExhibitDiscrepant Effects onthe DifferentiationofTLymphocyte Subsets.MolPharm.2019Feb4;16(2):798-807.doi:
10.1021/acs.molpharmaceut.8b01063.Epub2019Jan22. 32.XueweiWang#,ZhengtangLiu#,XinbingSui#,QibiaoWu*,JueWang,CongXu.Elemene injectionasadjunctivetreatment toplatinum-basedchemotherapyinpatients withstage III/IV non-smallcelllungcancer:ameta-analysis followingthe PRISMAguidelines,Phytomedicine. 2019Jun;59:152787.doi:10.1016/j.phymed.2018.12.010.
33.JueWang#,Guochun Li#,LiliYu#,TingtingMo,QibiaoWu*,ZhouZhou.Aidiinjectionplus platinum-basedchemotherapyforstageIIIB/IVnon-small celllungcancer:Ameta-analysis of42 RCTsfollowingthe PRISMAguidelines.JEthnopharmacol.2018Jul15;221:137-150.doi: 10.1016/j.jep.2018.04.013.
34. ZhouZhou#,WeixingShen#,LiliYu#,CongXu,QibiaoWu*.AChinese patentmedicine,Shexiang BaoxinPill,forNon-ST-elevationacutecoronarysyndromes:Asystematic review.J Ethnopharmacol.2016,194:1130-1139.doi:10.1016/j.jep.2016.11.024.
35. QibiaoWu*,WeixingShen, HaiboCheng,XiqiaoZhou.Long-termmacrolides fornon-cystic fibrosis bronchiectasis:Asystematic reviewand meta-analysis.Respirology,2014,19:321–329. doi:10.1111/resp.12233.
36. QibiaoWu*,Haitao Li,YujingLeng,HaishanDeng,HaiboCheng,WeixingShen*. DeterminationofMusconeinRatsPlasma following OralAdministrationofArtificialMusk: UsingofCombinedHeadspaceGasChromatography-Mass Spectrometry,Journal ofSpectroscopy, 2014,906928.https://doi.org/10.1155/2014/906928.
37. 李超，于丽丽，吴其标*. 阻塞型睡眠呼吸暂停低通气综合症（鼾眠）中西医结合治疗进展. 现 代中西医结合杂志.2020,29(27):105-107.
38. 徐航，叶小卫*，吴其标*.（2019）复方苦参注射液联合TACE治疗原发性肝癌临床研究进展. 中医药导报， 2019， 25(1)： 76-78,85.
39. 王珏，吴其标*. 艾迪注射液治疗中晚期非小细胞肺癌临床研究进展. 中医药导报，2017，23 （13）：70-75
40. 徐聪，吴其标*. 华蟾素治疗非小细胞肺癌的临床研究进展. 中医药导报，2017，23（17）： 100-103.
专著章节： 1.中西医临床诊疗技术，东南大学出版社，2004 2.急诊医学，东南大学出版社，2004 3.实用验方大全，东南大学出版社，2004 4.内科学，湖南科技出版社，2002
会议论文（部分）：
1. QibiaoWu*,XiaojunYao#,HongweiChen#,ElaineLai HanLeung*.Theefficacyandsafetyof long-termaspirinuseforcancerprimaryprevention: anupdatedsystematic reviewandsubgroup meta-analysis ofrandomizedcontrolledtrials.2019International ConferenceonAdvanced Bioinformaticsand Biomedical Engineering(ICABB 2019)(2019·Seoul·SouthKorea)
2. JueWang,Cong Xu,Xueli Cheng,Elaine Lai HanLeung*, QibiaoWu*.β-elemeneenhances antitumoractivityand induces apoptosisonTKI-resistantH1975lungcancercells byregulating AMPKαandMAPKpathways.The6thAnnualMeetingoftheSpecialty CommitteeonImmunologyof TraditionalChineseMedicine oftheWorldFederationofChineseMedicineSocieties cumthe Cross-Strait-Hong Kong-MacauForumonAdvancedResearchinTreatingRheumatismwith ChineseMedicine (2019·Tianjin·China).
3. HongweiChen, CairenWang,ChristopherWaiKeiLam,WeiZhang*, QibiaoWu*.Efficacyand safetyofShenqiFuzhenginjectioncombined withplatinum-basedchemotherapyforstageIII/IV non-smallcelllungcancer:Asystematic reviewandmeta-analysis ofrandomizedcontrolledtrials.The 6thAnnual Meetingofthe SpecialtyCommitteeonImmunology ofTraditionalChineseMedicine of theWorldFederationofChinese MedicineSocieties cumthe Cross-Strait- HongKong-MacauForum onAdvancedResearchinTreatingRheumatism withChineseMedicine (2019·Tianjin·China).
4. CongXu, JueWang,XueliCheng,Elaine Lai HanLeung*,QibiaoWu*.β-elemeneregulates oxidativestress toinduceapoptosis andincrease drugsensitivityofTKI-resistant NSCLC cells.The 6thAnnual Meetingofthe SpecialtyCommitteeonImmunology ofTraditionalChineseMedicine of theWorldFederationofChinese MedicineSocieties cumthe Cross-Strait- HongKong-MacauForum onAdvancedResearchinTreatingRheumatism withChineseMedicine (2019·Tianjin·China).
5. Ruo-NanZhang, BiChen,JueWang,Cong Xu,Elaine Lai HanLeung*,QibiaoWu*.β-elemene inhibits themetastasis ofKDM6A-deficientbladdercancercells byinhibitingtheepithelialmesenchymaltransition.The6thAnnual Meeting ofthe SpecialtyCommittee onImmunologyof TraditionalChineseMedicine oftheWorldFederationofChineseMedicineSocieties cumthe Cross-Strait-HongKong-MacauForumonAdvancedResearch inTreatingRheumatismwith ChineseMedicine (2019·Tianjin·China).
6. QiaoWang,XuShu,JingWang,BoAn,QibiaoWu*.Textual researchonthe namesof“Painand Numbness”disease.The 6thAnnualMeetingofthe SpecialtyCommitteeonImmunology of TraditionalChineseMedicine oftheWorldFederationofChineseMedicineSocieties cumthe Cross-Strait-Hong Kong-MacauForumonAdvancedResearchinTreatingRheumatismwith ChineseMedicine (2019·Tianjin·China).
7. BiChen, Ruo NanZhang, JueWang, Cong Xu,XinbingSui*, ElaineLai Han Leung*, QibiaoWu*. The role of traditional Chinese medicine in reducing the adverse reactions caused by cancer immunotherapy. The 6th Annual Meeting of the Specialty Committee on Immunology of Traditional Chinese Medicine of the World Federation of Chinese Medicine Societies cum the Cross-Strait- Hong Kong-Macau Forum on Advanced Research in Treating Rheumatism with Chinese Medicine (2019·Tianjin·China).
8. WangJing,QiaoWang,BoAn, QibiaoWu*.Meta-analysis ofCompoundHong-dou-shan capsule combinedwithradiotherapyorchemotherapyformalignanttumors.The6thAnnualMeetingofthe SpecialtyCommitteeonImmunologyofTraditionalChinese MedicineoftheWorldFederationof ChineseMedicine Societiescum theCross-Strait-HongKong-Macau ForumonAdvancedResearchin TreatingRheumatismwithChineseMedicine (2019·Tianjin·China).
9. XueweiWang,JueWang,QibiaoWu*.Elemene injectionasadjunctivetreatment to platinum-basedchemotherapyforadvanced non-small celllungcancer:asystematic reviewand meta-analysis.Proceedings ofthe 5thAnnual Meetingofthe SpecialtyCommitteeonImmunology of TraditionalChineseMedicine oftheWorldFederationofChineseMedicineSocietiescum the
Cross-StraitForumonAdvancedResearchonTreatmentofRheumatismwithChinese Medicine(2018· Nanning·China)
10.JueWang,Elaine LaihanLeung*,QibiaoWu*.Asystematic reviewand meta-analysisof randomizedcontrolledtrials ofAidiinjectionincombinationwithchemotherapyformiddle-advanced stagenon-small celllungcancer.Proceedings ofthe 5thAnnualMeetingofthe SpecialtyCommitteeon ImmunologyofTraditionalChineseMedicine oftheWorldFederationofChineseMedicine SocietiescumtheCross-Strait ForumonAdvancedResearchonTreatment ofRheumatism with ChineseMedicine,(2018Nanning·China)
11. QibiaoWu* Current Development andFuture Perspectives of Simulation-basedMedical EducationinMacau.Proceedings ofthe InternationalConferenceforMultipleAcademic Disciplines (2018·Geneva·Switzerland).
12. WeixingShen,QibiaoWu*,ZhiruoZhou,Zhengjie Shen,HaiboCheng*.Themechanisms and Effectiveness ofXiao-Ai-Jie-Du-Fang ondifferentiationtumor-associatedmacrophages.Proceedings oftheInaugural ConferenceoftheSpecialty CommitteeonImmunologyofTraditionalChinese MedicineofWorldFederationofChineseMedicineSocieties (2014·Guangzhou·China）
13. QibiaoWu*,HaitaoLi,YujingLeng,HaishanDeng,HaiboCheng,WeixingShen.Determination ofmusconeinplasma ofratsfollowingoraladministrationofartificial musk:useofcombined headspacegas chromatography-massspectrometryProceedings ofthe 11thMeetingofConsortiumfor GlobalizationofChineseMedicine(CGCM)(2012·Macau·China).
2020 高级生物信息学和生物医学工程国际会议（ICABB2020）项目主席 澳门中华中医药学会副理事长
江苏省研究型医院协会微生态委员会副主任委员
江苏省抗衰老协会亚健康研究委员办公室副主任
世界中医药学会联合会中医药免疫专业委员会常务理事
澳门风湿病研究国际合作联盟理事
两岸四地中医药科技合作中心理事会理事
世界中医药学会联合会急症专业委员会委员 亚太呼吸学会（ASAP）会员 美国医生学院（ACP）会员 中国抗癌协会会员
中西医整合肿瘤专业委员会委员
澳门高等教育发展促进会会员
澳门中医药学会会员
澳门新华中医内科协会顾问
澳门科学技术发展基金、澳门基金会项目、广东省基础与应用基础研究（省自然科学基金）项目
等评审专家